期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

微小RNA-7的研究进展 被引量：7

原文传递
导出
摘要 微小RNA-7(miR-7)是于2001年由Lagos首次报道的一类非编码小分子RNA。在人和小鼠的基因组序列中均有三种不同的DNA序列可以转录加工为成熟的miR-7分子。近来的研究显示,miR-7在大脑、胰腺等器官发育以及相关临床疾病的发生中发挥了重要作用。本文中,我们分别从组织器官发育和临床疾病两方面对miR-7相关研究进展进行综述。
作者 褚风云 郭萌萌 陈超 徐林
机构地区 遵义医学院免疫学教研室暨贵州省生物治疗人才基地 贵州省普通高等学校特色药物肿瘤防治特色重点实验室
出处 《现代免疫学》 CAS CSCD 北大核心 2016年第4期345-349,共5页 Current Immunology
基金 国家自然科学基金(31370918) 贵州省高层次创新型人才计划[黔科合人才(2016)4031号] 遵义医学院优秀青年人才计划项目(15ZY-001)
关键词 微小RNA-7 器官发育 肿瘤 生物治疗
分类号 R392.12 [医药卫生—免疫学]
  • 相关文献

参考文献39

  • 1ShenoyA, Blelloch RH. Regulation of microRNA function in somatic stem cell proliferation and differentiation[J]. Nat Rev Mol Cell Bioi, 2014,15: 565-576.
  • 2Reddy SD, Ohshiro K, Rayala SK,et al. MicroRNA-7, a ho?meobox 010 target, inhibits p21-activated kinase 1 and regu?la tes its f unctions[J]. Cancer Res, 2008 , 68 : 8195-8200.
  • 3Chou YT, Lin HH, Lien YC, et ala EGFR promotes lung tumorigenesis by activating miR-7 through a Ras/ERK/Myc pathway that targets the Ets2 transcriptional repressor ERF [J]. Cancer Res,2010,70:8822-8831.
  • 4BaskervilleS, Bartel DP. Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes[J] . RNA, 2005,11 : 241-247.
  • 5Horsham JL, Kalinowski Fe, Epis MR,etal. Clinical Poten?tial of microRNA-7 in Cencerj J}. J Clin Med, 2015,4: 1668- 1687.
  • 6Li X, Cassidy JJ, Reinke CA, et al. A microRNA imparts robustness against environmental fluctuation during develop?ment[J].Cell, 2009,137: 273-282.
  • 7Bak M, Silahtaroglu A, Moller M, etal. MicroRNA expres?sion in the adult mouse central nervous system[J]. RNA, 2008,14: 432-444.
  • 8Chen H, Shalom-Feuerstein R, Riley J, et at. miR-7 and miR-214 are specifically expressed during neuroblastoma dif?ferentiation, cortical development and embryonic stem cells differentiation, and control neurite outgrowth in vitro [J]. Biochem Biophys Res Commun , 2010 , 394 : 921-927.
  • 9Pollock A, Bian S, Zhang C.et al. Growth of the developing cerebral cortex is controlled by microRNA-7 through the p53 pathway[J]. Cell Rep, 2014,7 : 1184-1196.
  • 10Stevanato L, Sinden JD. The effects of microRNAs on hu?man neural stem cell differentiation in two- and three-dimen?sional cuI tures[J]. Stem Cell Res Ther , 2014 , 5 : 1-11.

二级参考文献53

  • 1卜友泉,杨正梅,宋方洲.新基因功能研究的策略与方法[J].生命科学研究,2006,10(S1):95-98. 被引量：12
  • 2徐林,任涛,周涯,秦安东,郑静.微小RNA-7对人肺癌95D细胞体外增殖的作用[J].肿瘤,2010,30(9):763-767. 被引量：19
  • 3Hall RD, Gray JE, Chiappori AA. Beyond the standard of care: a review of novel immunotherapy trials for the treatment of lung cancer [J]. Cancer Control, 2013, 20(1): 22-31.
  • 4Farazi TA, Hoell JI, Morozov P, et al. MicroRNAs in human cancer [J]. Adv Exp Med Biol, 2013, 774:1 -20.
  • 5Chen PS, Su JL, Hung MC. Dysregulation of microRNAs in cancer [J/OA]. J Biomed Sci, 2012, 19: 90.
  • 6Xiong S, Zheng Y, Jiang P, et al. MicroRNA-7 inhibits the growth of human non-small cell lung cancer A549 cells through targeting BCL-2[J]. Iut J Biol Sei, 2011,7(6) : 805 -814.
  • 7Webster RJ, Giles KM, Price KJ, et al. Regulation of epidermal growth factor receptor signaling in human cancer cells by microRNA- 7[J]. J Biol Chem, 2009, 284(9): 5731 -5741.
  • 8Xu L, Wen Z, Zhou Y, et al. MicroRNA-7-regulated TIa~,9 signaling- enhanced growth and metastatic potential of human lung cancer cells by altering the phosphoinositide-3-kinase, regulatory subunit 3/Akt pathway [J]. Mol Biol Cell, 2013, 24(1) : 42 -55.
  • 9Yu N, Huangyang P, Yang X, et al. microRNA-7 suppresses the invasive potential of breast cancer cells and sensitizes cells to DNA damages by targeting histone methyltransferase SET8 [ J ]. J Biol Chem, 2013, 288(27) : 19633 - 19642.
  • 10Rai K, Takigawa N, Ito S, et al. Liposomal delivery of MicroRNA-7- expressing plasmid overcomes epidermal growth factor receptor tyrosine kinase inhibitor-resistance in lung cancer ceils [ J ]. Mol Cancer T her, 2011, 10(9): 1720-1727.

共引文献28

同被引文献37

引证文献7

二级引证文献20

现代免疫学
2016年 第4期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部